World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
18169
World Ranking
2066
National Ranking
1008

Medicine

D-Index
74
Citations
18169
World Ranking
19459
National Ranking
9688

Leonidas Stamatatos publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Leonidas Stamatatos sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 209 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Leonidas Stamatatos D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Leonidas Stamatatos sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Leonidas Stamatatos is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on medicine and immunology and microbiology, with significant contributions to the subfields of infectious diseases, immunology, virology, radiology, nuclear medicine and imaging, and molecular biology.

Their research covers several main topics including SARS-CoV-2 and COVID-19 research, HIV research and treatment, monoclonal and polyclonal antibodies research, immune cell function and interaction, T-cell and B-cell immunology, COVID-19 clinical research studies, and SARS-CoV-2 detection and testing.

Recent notable publications by Leonidas Stamatatos include:

  • mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021, Science)
  • Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation (2020, Immunity)
  • Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study (2021, Science)
  • Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy (2021, Immunity)
  • A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses (2021, Cell Host & Microbe)

Their frequent co-authors include:

  • Andrew T. McGuire
  • Anna J. MacCamy
  • Marie Pancera
  • Yu-Hsin Wan
  • Leah J. Homad

Publication venues where Leonidas Stamatatos has frequently published include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell Reports
  • Science
  • Immunity
  • The Journal of Experimental Medicine

Best Publications

  • Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    Ming Li;Feng Gao;John R. Mascola;Leonidas Stamatatos

  • Rational HIV immunogen design to target specific germline B cell receptors

    Joseph Jardine;Jean Philippe Julien;Jean Philippe Julien;Sergey Menis;Takayuki Ota

  • Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection

    D. Noah Sather;Jakob Armann;Jakob Armann;Lance K. Ching;Lance K. Ching;Angeliki Mavrantoni;Angeliki Mavrantoni

  • Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

    Leonidas Stamatatos;Leonidas Stamatatos;Lynn Morris;Dennis R Burton;John R Mascola

  • mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.

    Leonidas Stamatatos;Leonidas Stamatatos;Julie Czartoski;Yu Hsin Wan;Leah J. Homad

  • Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes.

    Leonidas Stamatatos;Rania Leventis;Martin J. Zuckermann;John R. Silvius

  • Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1

    Iliyana Mikell;D. Noah Sather;Spyros A. Kalams;Marcus Altfeld

  • Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.

    Emilie Seydoux;Leah J. Homad;Anna J. MacCamy;K. Rachael Parks;K. Rachael Parks

  • Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies

    Andrew T. McGuire;Sam Hoot;Anita M. Dreyer;Adriana Lippy

  • The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

    S. W. Barnett;S. Lu;I. Srivastava;S. Cherpelis

  • Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

    Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  • Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice

    Pia Dosenovic;Lotta Von Boehmer;Amelia Escolano;Joseph Jardine

  • Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.

    Kathryn M. Hastie;Haoyang Li;Daniel Bedinger;Sharon L. Schendel

  • Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope

    Bruno E. Correia;Yih En Andrew Ban;Margaret A. Holmes;Hengyu Xu

  • An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades.

    Leonidas Stamatatos;Cecilia Cheng-Mayer

  • Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.

    Ming Tian;Ming Tian;Cheng Cheng;Xuejun Chen;Hongying Duan

  • Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

    Indresh K. Srivastava;Leonidas Stamatatos;Elaine Kan;Michael Vajdy

  • Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs

    Sam Hoot;Andrew T. McGuire;Kristen W. Cohen;Kristen W. Cohen;Roland K. Strong

  • N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.

    Ruth A. McCaffrey;Cheryl Saunders;Mike Hensel;Mike Hensel;Leonidas Stamatatos;Leonidas Stamatatos

  • V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein with CD4 and CCR5 Receptors and Protects the Virus from Neutralization by Anti-V3 Loop and Anti-CD4 Binding Site Antibodies

    Amy Ly;Leonidas Stamatatos

  • Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy.

    Irfan Ullah;Jérémie Prévost;Mark S. Ladinsky;Helen Stone

Frequent Co-Authors

Michel C. Nussenzweig
Michel C. Nussenzweig Rockefeller University
Marie Pancera
Marie Pancera Fred Hutchinson Cancer Research Center
Susan W. Barnett
Susan W. Barnett Bill & Melinda Gates Foundation
Roland K. Strong
Roland K. Strong Fred Hutchinson Cancer Research Center
William R. Schief
William R. Schief Scripps Research Institute
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
David C. Montefiori
David C. Montefiori Duke University
Nancy L. Haigwood
Nancy L. Haigwood Oregon Health & Science University
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Pamela J. Bjorkman
Pamela J. Bjorkman California Institute of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Programs like the top pmhnp programs offer advanced training in psychiatric nursing, which complements immunological studies with a focus on mental health and patient care.

Cost is often a major consideration, and students can find high-quality education through the cheapest online pmhnp programs. These affordable options make it easier for aspiring professionals to achieve advanced credentials without excessive financial burden.

Career advancement often depends on understanding salary landscapes. Resources like dnp salary transparency provide valuable insights into Doctor of Nursing Practice salaries across states, helping graduates make informed decisions about their job locations and expectations.

Additionally, transitioning between specialties is common in healthcare. For instance, learning how to shift from a Family Nurse Practitioner role to more specialized fields can enhance one’s career prospects. The guide on fnp to acute care np outlines practical steps to achieve such transitions smoothly.

Best Scientists Citing Leonidas Stamatatos

Trending Scientists

Recently Published Articles